Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 16-Jul-2021
No. of pages: 100
Inquire Before Buying

Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose any symptom but in severe cases it can cause pain during urination and can cause problem during sexual intercourse. Castration resistant prostate cancer is referred to as a prostate cancer that is spread to other parts of body and is resistant to medical or surgical treatment. Risk factor for castration resistant prostate cancer includes genetic predisposition, geriatric population, unhygienic diet, medication exposure and many sexual partners. Diagnosis for the detection of castration resistant prostate cancer includes prostate imaging, biopsy, tumor marker and staging test. Crucial factor about castration resistant prostate cancer is that it is resistant to medical and surgical treatment. However, other treatment options that are available in the market include hormone therapy, immune modulation, antiangiogenic treatment and bone targeted therapies.

North America dominates the global market for castration resistant prostate cancer treatment due to presence of large prostate cancer population in this region. Moreover, increasing demand of diagnostic test, increasing awareness among people and initiative taken by the federal government also accounted for the market growth in North American region. Europe represents the second position in the global castration resistant prostate cancer treatment market due to presence of large geriatric population base in European region. Asia-Pacific is considered as an untapped market due to lack of awareness and lack of proper healthcare facilities in some Asian countries. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in the healthcare infrastructure (healthcare cost, healthcare facility and healthcare budget). Similarly, Asia-Pacific is considered as an emerging market during the study period due to growing market penetration in this region.

Market Analysis and Insights: Global Castration Resistant Prostate Cancer Treatment Market

The global Castration Resistant Prostate Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Castration Resistant Prostate Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Castration Resistant Prostate Cancer Treatment market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Castration Resistant Prostate Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Castration Resistant Prostate Cancer Treatment market.

Global Castration Resistant Prostate Cancer Treatment Scope and Market Size

Castration Resistant Prostate Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Castration Resistant Prostate Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Hormonal Therapy

- Adding An Anti-Androgen

- Stopping An Anti-Androgen

- Estrogens

- Chemotherapy

- Radiation Therapy

- Others

Segment by Application

- Hospital

- Ambulatory Surgical Centers

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Active Biotech

- Diagnocure

- Glaxosmithkline

- Northwest Biotherapeutics

- Millennium Pharmaceuticals

- Hologic

- Spectrum Pharmaceuticals

- Abbott Laboratories

- Bayer Healthcare Pharmaceuticals

Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Hormonal Therapy
1.2.3 Adding An Anti-Androgen
1.2.4 Stopping An Anti-Androgen
1.2.5 Estrogens
1.2.6 Chemotherapy
1.2.7 Radiation Therapy
1.2.8 Others
1.3 Market by Application
1.3.1 Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Castration Resistant Prostate Cancer Treatment Market Perspective (2016-2027)
2.2 Castration Resistant Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Castration Resistant Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Castration Resistant Prostate Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Castration Resistant Prostate Cancer Treatment Industry Dynamic
2.3.1 Castration Resistant Prostate Cancer Treatment Market Trends
2.3.2 Castration Resistant Prostate Cancer Treatment Market Drivers
2.3.3 Castration Resistant Prostate Cancer Treatment Market Challenges
2.3.4 Castration Resistant Prostate Cancer Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue
3.1.1 Global Top Castration Resistant Prostate Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Castration Resistant Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Castration Resistant Prostate Cancer Treatment Revenue
3.4 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Castration Resistant Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Castration Resistant Prostate Cancer Treatment Revenue in 2020
3.5 Castration Resistant Prostate Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service
3.7 Date of Enter into Castration Resistant Prostate Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Castration Resistant Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027)
5 Castration Resistant Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Castration Resistant Prostate Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
6.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type
6.2.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Application
6.3.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Castration Resistant Prostate Cancer Treatment Market Size by Country
6.4.1 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
7.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type
7.2.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application
7.3.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country
7.4.1 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
9.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type
9.2.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application
9.3.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country
9.4.1 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Active Biotech
11.1.1 Active Biotech Company Details
11.1.2 Active Biotech Business Overview
11.1.3 Active Biotech Castration Resistant Prostate Cancer Treatment Introduction
11.1.4 Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.1.5 Active Biotech Recent Development
11.2 Diagnocure
11.2.1 Diagnocure Company Details
11.2.2 Diagnocure Business Overview
11.2.3 Diagnocure Castration Resistant Prostate Cancer Treatment Introduction
11.2.4 Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.2.5 Diagnocure Recent Development
11.3 Glaxosmithkline
11.3.1 Glaxosmithkline Company Details
11.3.2 Glaxosmithkline Business Overview
11.3.3 Glaxosmithkline Castration Resistant Prostate Cancer Treatment Introduction
11.3.4 Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.3.5 Glaxosmithkline Recent Development
11.4 Northwest Biotherapeutics
11.4.1 Northwest Biotherapeutics Company Details
11.4.2 Northwest Biotherapeutics Business Overview
11.4.3 Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Introduction
11.4.4 Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.4.5 Northwest Biotherapeutics Recent Development
11.5 Millennium Pharmaceuticals
11.5.1 Millennium Pharmaceuticals Company Details
11.5.2 Millennium Pharmaceuticals Business Overview
11.5.3 Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.5.4 Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.5.5 Millennium Pharmaceuticals Recent Development
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Castration Resistant Prostate Cancer Treatment Introduction
11.6.4 Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.6.5 Hologic Recent Development
11.7 Spectrum Pharmaceuticals
11.7.1 Spectrum Pharmaceuticals Company Details
11.7.2 Spectrum Pharmaceuticals Business Overview
11.7.3 Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.7.4 Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.7.5 Spectrum Pharmaceuticals Recent Development
11.8 Abbott Laboratories
11.8.1 Abbott Laboratories Company Details
11.8.2 Abbott Laboratories Business Overview
11.8.3 Abbott Laboratories Castration Resistant Prostate Cancer Treatment Introduction
11.8.4 Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.8.5 Abbott Laboratories Recent Development
11.9 Bayer Healthcare Pharmaceuticals
11.9.1 Bayer Healthcare Pharmaceuticals Company Details
11.9.2 Bayer Healthcare Pharmaceuticals Business Overview
11.9.3 Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Introduction
11.9.4 Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
11.9.5 Bayer Healthcare Pharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Castration Resistant Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Hormonal Therapy
Table 3. Key Players of Adding An Anti-Androgen
Table 4. Key Players of Stopping An Anti-Androgen
Table 5. Key Players of Estrogens
Table 6. Key Players of Chemotherapy
Table 7. Key Players of Radiation Therapy
Table 8. Key Players of Others
Table 9. Global Castration Resistant Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Castration Resistant Prostate Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Castration Resistant Prostate Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 12. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2016-2021)
Table 13. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 14. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2022-2027)
Table 15. Castration Resistant Prostate Cancer Treatment Market Trends
Table 16. Castration Resistant Prostate Cancer Treatment Market Drivers
Table 17. Castration Resistant Prostate Cancer Treatment Market Challenges
Table 18. Castration Resistant Prostate Cancer Treatment Market Restraints
Table 19. Global Castration Resistant Prostate Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 20. Global Castration Resistant Prostate Cancer Treatment Market Share by Players (2016-2021)
Table 21. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2020)
Table 22. Ranking of Global Top Castration Resistant Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 23. Global 5 Largest Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Castration Resistant Prostate Cancer Treatment Product Solution and Service
Table 26. Date of Enter into Castration Resistant Prostate Cancer Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 29. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 30. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 31. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 32. Global Castration Resistant Prostate Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 33. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 34. Global Castration Resistant Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 35. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 36. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 37. North America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 38. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 39. North America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 40. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 41. North America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 42. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 43. Europe Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 44. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 45. Europe Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 46. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 47. Europe Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 49. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 51. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 52. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 53. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 54. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 55. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 56. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 57. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 58. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 59. Latin America Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 61. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 63. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 64. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 65. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 66. Active Biotech Company Details
Table 67. Active Biotech Business Overview
Table 68. Active Biotech Castration Resistant Prostate Cancer Treatment Product
Table 69. Active Biotech Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 70. Active Biotech Recent Development
Table 71. Diagnocure Company Details
Table 72. Diagnocure Business Overview
Table 73. Diagnocure Castration Resistant Prostate Cancer Treatment Product
Table 74. Diagnocure Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 75. Diagnocure Recent Development
Table 76. Glaxosmithkline Company Details
Table 77. Glaxosmithkline Business Overview
Table 78. Glaxosmithkline Castration Resistant Prostate Cancer Treatment Product
Table 79. Glaxosmithkline Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 80. Glaxosmithkline Recent Development
Table 81. Northwest Biotherapeutics Company Details
Table 82. Northwest Biotherapeutics Business Overview
Table 83. Northwest Biotherapeutics Castration Resistant Prostate Cancer Treatment Product
Table 84. Northwest Biotherapeutics Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 85. Northwest Biotherapeutics Recent Development
Table 86. Millennium Pharmaceuticals Company Details
Table 87. Millennium Pharmaceuticals Business Overview
Table 88. Millennium Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 89. Millennium Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 90. Millennium Pharmaceuticals Recent Development
Table 91. Hologic Company Details
Table 92. Hologic Business Overview
Table 93. Hologic Castration Resistant Prostate Cancer Treatment Product
Table 94. Hologic Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 95. Hologic Recent Development
Table 96. Spectrum Pharmaceuticals Company Details
Table 97. Spectrum Pharmaceuticals Business Overview
Table 98. Spectrum Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 99. Spectrum Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 100. Spectrum Pharmaceuticals Recent Development
Table 101. Abbott Laboratories Company Details
Table 102. Abbott Laboratories Business Overview
Table 103. Abbott Laboratories Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 104. Abbott Laboratories Recent Development
Table 105. Bayer Healthcare Pharmaceuticals Company Details
Table 106. Bayer Healthcare Pharmaceuticals Business Overview
Table 107. Bayer Healthcare Pharmaceuticals Castration Resistant Prostate Cancer Treatment Product
Table 108. Bayer Healthcare Pharmaceuticals Revenue in Castration Resistant Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 109. Bayer Healthcare Pharmaceuticals Recent Development
Table 110. Research Programs/Design for This Report
Table 111. Key Data Information from Secondary Sources
Table 112. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Castration Resistant Prostate Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Hormonal Therapy Features
Figure 3. Adding An Anti-Androgen Features
Figure 4. Stopping An Anti-Androgen Features
Figure 5. Estrogens Features
Figure 6. Chemotherapy Features
Figure 7. Radiation Therapy Features
Figure 8. Others Features
Figure 9. Global Castration Resistant Prostate Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 10. Hospital Case Studies
Figure 11. Ambulatory Surgical Centers Case Studies
Figure 12. Castration Resistant Prostate Cancer Treatment Report Years Considered
Figure 13. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Castration Resistant Prostate Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 16. Global Castration Resistant Prostate Cancer Treatment Market Share by Regions (2022-2027)
Figure 17. Global Castration Resistant Prostate Cancer Treatment Market Share by Players in 2020
Figure 18. Global Top Castration Resistant Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Castration Resistant Prostate Cancer Treatment as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Castration Resistant Prostate Cancer Treatment Revenue in 2020
Figure 20. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 21. Global Castration Resistant Prostate Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 22. North America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 24. North America Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 25. North America Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 26. United States Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 30. Europe Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 31. Europe Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 32. Germany Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Castration Resistant Prostate Cancer Treatment Market Share by Region (2016-2027)
Figure 42. China Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 50. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 51. Latin America Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 52. Mexico Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Castration Resistant Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 58. Turkey Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Castration Resistant Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Active Biotech Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 62. Diagnocure Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 63. Glaxosmithkline Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 64. Northwest Biotherapeutics Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 65. Millennium Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 66. Hologic Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 67. Spectrum Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 68. Abbott Laboratories Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 69. Bayer Healthcare Pharmaceuticals Revenue Growth Rate in Castration Resistant Prostate Cancer Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed
  • Global Small Molecule Targeted Cancer Therapy Market Size, Status and Forecast 2021-2027
    Published: 19-Jul-2021        Price: US 3900 Onwards        Pages: 98
    Market Analysis and Insights: Global Small Molecule Targeted Cancer Therapy Market The global Small Molecule Targeted Cancer Therapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Small Molecule Targeted Cancer Therapy market to help players in achievin......
  • Global T-Cell Immunotherapy Market Size, Status and Forecast 2021-2027
    Published: 19-Jul-2021        Price: US 3900 Onwards        Pages: 96
    Market Analysis and Insights: Global T-Cell Immunotherapy Market The global T-Cell Immunotherapy market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global T-Cell Immunotherapy market to help players in achieving a strong market position. Buyers of the report can a......
  • Global Castration Resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
    Published: 16-Jul-2021        Price: US 3900 Onwards        Pages: 100
    Prostate cancer can be defined as it is a form of cancer that develops into male reproductive system. Most of the prostate cancer are slow growing and stable but sometimes it can spread from prostate (gland) to other part of body such as bone and lymph node. Initially prostate cancer does not pose any symptom but in severe cases it can cause pain during urination and can cause problem during sexual intercourse. Castration resistant prostate cancer is referred to as a prostate cancer that is spre......
  • Oligodendroglioma - Global Clinical Trials Review, H2, 2021
    Published: 16-Jul-2021        Price: US 2500 Onwards        Pages: 233
    Oligodendroglioma - Global Clinical Trials Review, H2, 2021 Summary GlobalData's clinical trial report, "Oligodendroglioma - Global Clinical Trials Review, H2, 2021" provides an overview of Oligodendroglioma Clinical trials scenario. This report provides top line data relating to the clinical trials on Oligodendroglioma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of di......
  • Global Ovarian Cancer Therapeutics Market Size, Status and Forecast 2021-2027
    Published: 16-Jul-2021        Price: US 3900 Onwards        Pages: 96
    Ovarian cancer, and its rising incidence rate, is a growing concern worldwide. Market players that are currently engaged in the development of drugs and therapies for ovarian cancer stand to benefit by observing the latest trends and pipeline competitor products. Market Analysis and Insights: Global Ovarian Cancer Therapeutics Market The global Ovarian Cancer Therapeutics market size is projected to reach US$ 2557.7 million by 2027, from US$ 1764.3 million in 2020, at a CAG......
  • Global Non-Melanoma Skin Cancer Market Size, Status and Forecast 2021-2027
    Published: 15-Jul-2021        Price: US 3900 Onwards        Pages: 124
    Non-melanoma skin cancer is usually treated as a simple lesion in the initial stages but if not treated properly, it can quickly mushroom and spread to other body parts. Radiation therapy has a market share approaching 88% in the non-melanoma skin cancer treatment market in 2017 itself and is unlikely to cede this commanding position anytime soon. Market Analysis and Insights: Global Non-Melanoma Skin Cancer Market The global Non-Melanoma Skin Cancer market size is p......
  • Global Glioblastoma Multiforme Treatment Market Size, Status and Forecast 2021-2027
    Published: 15-Jul-2021        Price: US 3900 Onwards        Pages: 109
    Market Analysis and Insights: Global Glioblastoma Multiforme Treatment Market The global Glioblastoma Multiforme Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Glioblastoma Multiforme Treatment market to help players in achieving a strong mark......
  • Medulloblastoma - Global Clinical Trials Review, H2, 2021
    Published: 15-Jul-2021        Price: US 2500 Onwards        Pages: 170
    Medulloblastoma - Global Clinical Trials Review, H2, 2021 Summary GlobalData's clinical trial report, "Medulloblastoma - Global Clinical Trials Review, H2, 2021" provides an overview of Medulloblastoma Clinical trials scenario. This report provides top line data relating to the clinical trials on Medulloblastoma. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease cl......
  • Gallbladder Cancer - Global Clinical Trials Review, H2, 2021
    Published: 14-Jul-2021        Price: US 2500 Onwards        Pages: 300
    Gallbladder Cancer - Global Clinical Trials Review, H2, 2021 Summary GlobalData's clinical trial report, "Gallbladder Cancer - Global Clinical Trials Review, H2, 2021" provides an overview of Gallbladder Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials on Gallbladder Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage o......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected]rch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs